Tumours of skin, breast and thyroid
The common surgical tumours of three accessible organs as illustrations of general principles of neoplasia: precursor lesions, histological types and their behaviour, routes of spread, the prognostic factors that guide treatment, and the role of receptors and molecular changes in breast cancer and of cell of origin in thyroid cancer.
By the end of this page you should be able to
- Describe the pathology, behaviour and prognostic factors of basal cell carcinoma, squamous cell carcinoma and melanoma, including their precursors.
- Classify benign and malignant breast lesions and describe the pathology of ductal carcinoma in situ and invasive carcinoma.
- Explain the prognostic and predictive factors in breast cancer, including receptor status.
- Classify thyroid tumours by cell of origin and describe their behaviour and spread.
- Apply general principles of neoplasia (in situ disease, grade, stage, routes of spread) to these tumours.
Skin
Ultraviolet radiation is the main cause of skin cancer: UVB directly damages DNA, forming pyrimidine dimers, and mutations in genes such as TP53 (keratinocyte cancers) follow. Risk rises with fair skin, cumulative and intermittent sun exposure, age, immunosuppression (especially after organ transplantation, where squamous cell carcinoma becomes far commoner), and inherited syndromes. Australia and New Zealand have the highest incidence in the world.
Basal cell carcinoma is the commonest. It arises from the basal layer of the epidermis and hair follicles, typically on sun-exposed skin of the head and neck, as a pearly nodule with telangiectasia and rolled edges, which may ulcerate (rodent ulcer). Histology shows nests of basaloid cells with peripheral palisading and retraction artefact from the stroma. It invades locally and can destroy deep structures, but metastasis is very rare. Subtypes matter: morphoeic (infiltrative) tumours have ill-defined margins and recur more often. Mutations in the Hedgehog pathway (PTCH1) underlie most tumours and the naevoid basal cell carcinoma syndrome.
Squamous cell carcinoma arises from keratinocytes, often from a precursor: actinic (solar) keratosis (dysplasia confined to part of the epidermis) and Bowen disease (full-thickness squamous cell carcinoma in situ). Invasive tumours show nests of atypical squamous cells with keratin pearls and intercellular bridges invading the dermis. They can metastasise, usually to regional lymph nodes, with higher risk for tumours that are thick, poorly differentiated, recurrent, with perineural invasion, on the lip or ear, arising in scars or chronic ulcers (a Marjolin ulcer), or in the immunosuppressed. A keratoacanthoma grows rapidly and may regress, but is hard to separate from squamous cell carcinoma, and is treated similarly.
Melanoma arises from melanocytes in the basal layer, sometimes from a pre-existing naevus but mostly de novo. Clinical features of concern include asymmetry, irregular borders, colour variation, diameter and evolution, and a new or changing lesion. Growth patterns include superficial spreading (the commonest, with a radial growth phase), nodular (vertical growth from the start, so thick at presentation), lentigo maligna (on chronically sun-damaged skin of the elderly) and acral lentiginous (palms, soles and nail beds). Prognosis depends mainly on Breslow thickness (in millimetres from the granular layer to the deepest invasive cell), ulceration and mitotic rate, then on sentinel node status and distant metastasis. Melanoma spreads by lymphatics (to in-transit and nodal sites) and by blood to almost any organ. BRAF mutations are present in about 40% of cutaneous melanomas and predict response to targeted inhibitors.
Breast: benign lesions
- Fibroadenoma: a benign biphasic tumour of stroma and epithelium, typically a mobile, well-circumscribed lump in young women ("breast mouse"); it may enlarge in pregnancy and regress after menopause.
- Phyllodes tumour: also biphasic but with a cellular, leaf-like stroma; ranges from benign to malignant and recurs locally if not excised with a margin; malignant forms spread by blood, not lymph.
- Fibrocystic change: cysts, fibrosis and adenosis; no increased cancer risk unless there is epithelial hyperplasia. Usual ductal hyperplasia slightly increases risk; atypical ductal or lobular hyperplasia increases it several fold.
- Intraductal papilloma: a cause of bloody nipple discharge, usually benign.
- Fat necrosis: after trauma or surgery; it can mimic cancer clinically and radiologically, with a hard, tethered lump and calcification.
- Duct ectasia and periductal mastitis: dilated subareolar ducts with inflammation, associated with smoking; can cause nipple retraction and fistula.
Breast: carcinoma
Risk factors reflect lifetime oestrogen exposure (early menarche, late menopause, nulliparity, late first pregnancy, hormone replacement, obesity after menopause), age, family history and inherited mutations, especially BRCA1 and BRCA2 (tumour suppressor genes involved in DNA repair by homologous recombination), previous radiation and atypical hyperplasia.
Almost all breast cancers are adenocarcinomas arising from the terminal duct lobular unit. Ductal carcinoma in situ (DCIS) is malignant epithelium confined within the ducts by an intact basement membrane, often detected as microcalcification on mammography; high-grade DCIS with comedo necrosis is more likely to progress. It cannot metastasise while in situ. Lobular carcinoma in situ is a marker of increased risk in both breasts as much as a precursor.
Invasive carcinoma of no special type (formerly invasive ductal) is the commonest, forming a hard, stellate mass with a desmoplastic stroma. Invasive lobular carcinoma (about 10 to 15%) grows in single files of cells because of loss of the adhesion molecule E-cadherin, is often multifocal and bilateral, may be hard to see on imaging, and spreads to unusual sites (peritoneum, meninges, gut). Special types such as tubular and mucinous carcinoma have a better prognosis. Inflammatory carcinoma is a clinical presentation with dermal lymphatic invasion causing a red, swollen breast with peau d'orange and a poor prognosis. Paget disease of the nipple is an eczema-like change caused by malignant cells in the epidermis, nearly always with an underlying carcinoma.
Prognostic factors predict outcome: tumour size, nodal status (the most important), distant metastasis, histological grade (tubule formation, nuclear pleomorphism and mitotic count), lymphovascular invasion and margin status. Predictive factors predict response to a particular treatment: oestrogen and progesterone receptor status (endocrine therapy) and HER2 amplification (anti-HER2 therapy). These define molecular subtypes: luminal A (receptor positive, low proliferation, best prognosis), luminal B, HER2-enriched and triple negative (often basal-like, associated with BRCA1, aggressive, with early recurrence). Spread is to axillary and internal thoracic nodes, then to bone, lung, liver and brain; bone metastases are often lytic and cause hypercalcaemia.
Thyroid
A thyroid nodule is common; most are benign colloid nodules or adenomas. Thyroid cancers are classified by cell of origin.
From follicular cells: papillary carcinoma (about 80 to 85%), the commonest, linked to radiation exposure in childhood and to BRAF and RET rearrangements. Histology shows papillae with characteristic nuclei: clear, overlapping, ground-glass nuclei with grooves and pseudo-inclusions, and psammoma bodies. Diagnosis rests on the nuclear features, so it can be made on fine needle aspiration cytology. It spreads by lymphatics to cervical nodes, but prognosis is excellent. Follicular carcinoma is diagnosed only by capsular or vascular invasion on histology, so fine needle aspiration cannot distinguish it from a follicular adenoma. It spreads by blood to bone and lung. Both differentiated cancers take up iodine and make thyroglobulin, which allows radioiodine treatment and thyroglobulin follow-up. Anaplastic carcinoma affects the elderly, often arising from a long-standing differentiated tumour, grows rapidly with tracheal compression, and has a very poor prognosis.
From parafollicular C cells (neural crest origin): medullary carcinoma secretes calcitonin (a tumour marker) and shows amyloid in its stroma. A quarter are familial, from germline RET proto-oncogene mutations in multiple endocrine neoplasia type 2 (with phaeochromocytoma, and hyperparathyroidism in 2A), so screening relatives and excluding phaeochromocytoma before surgery matter. It does not take up iodine.
Lymphoma of the thyroid, usually B cell, arises in a background of Hashimoto thyroiditis.
Making the answer flow
- For each tumour: cell of origin, precursor, gross and microscopic features, behaviour and spread, prognostic factors.
- Separate prognostic from predictive factors in breast cancer, and say what each receptor predicts.
- Classify thyroid cancer by cell of origin first; link that to markers, iodine uptake and familial syndromes.
- Use these organs to illustrate in situ disease, grade and stage, and lymphatic versus blood spread.
Common traps
- Saying basal cell carcinoma metastasises often; it rarely does, but can be locally destructive.
- Saying follicular carcinoma can be diagnosed on cytology.
- Measuring melanoma thickness from the skin surface rather than the granular layer.
- Calling hormone receptor status a prognostic factor only; it predicts response to endocrine therapy.
- Forgetting to exclude phaeochromocytoma before surgery for medullary carcinoma.
Where this meets surgical practice
- Melanoma excision margins and the need for sentinel node biopsy are set by Breslow thickness.
- Follicular thyroid carcinoma cannot be diagnosed on fine needle aspiration because the diagnosis requires capsular or vascular invasion.
Test yourself
Answer each one aloud or on paper before you open the model points; explaining the mechanism is what makes the MCQ options easy to judge.
- 1.
Compare basal cell carcinoma and squamous cell carcinoma of the skin.
Show answer
- BCC: basal layer origin, peripheral palisading, locally invasive, metastasis very rare.
- SCC: keratinocyte origin, keratin pearls, arises from actinic keratosis or Bowen disease.
- SCC can spread to regional nodes, more so on lip and ear, in scars and in the immunosuppressed.
- Both caused mainly by ultraviolet exposure.
- 2.
What determines the prognosis of melanoma?
Show answer
- Breslow thickness from granular layer to deepest invasive cell.
- Ulceration and mitotic rate.
- Sentinel node status and distant metastasis.
- Site and growth pattern; nodular tumours present thicker.
- 3.
What is ductal carcinoma in situ?
Show answer
- Malignant epithelial cells confined within ducts by an intact basement membrane.
- Often found as microcalcification on screening mammography.
- Cannot metastasise while in situ; high-grade with comedo necrosis is more likely to progress.
- Treated to prevent invasive cancer.
- 4.
How does invasive lobular carcinoma differ from invasive carcinoma of no special type?
Show answer
- Loss of E-cadherin, so cells infiltrate in single files.
- Often multifocal and bilateral, may be hard to see on imaging.
- Spreads to unusual sites such as peritoneum, meninges and gut.
- Usually hormone receptor positive.
- 5.
What are prognostic and predictive factors in breast cancer?
Show answer
- Prognostic: size, nodal status, grade, lymphovascular invasion, distant metastasis.
- Predictive: oestrogen and progesterone receptors for endocrine therapy; HER2 for anti-HER2 therapy.
- Molecular subtypes combine them: luminal A, luminal B, HER2-enriched, triple negative.
- Triple negative tumours are aggressive and linked to BRCA1.
- 6.
Which breast lesions increase cancer risk?
Show answer
- Fibrocystic change without hyperplasia: no increase.
- Usual ductal hyperplasia: slight increase.
- Atypical ductal or lobular hyperplasia: several fold.
- Lobular carcinoma in situ: increased risk in both breasts.
- 7.
Compare papillary and follicular thyroid carcinoma.
Show answer
- Papillary: commonest, nuclear features (ground-glass, grooves, inclusions), psammoma bodies, diagnosed on cytology.
- Papillary spreads by lymphatics to neck nodes; excellent prognosis.
- Follicular: diagnosed only by capsular or vascular invasion on histology; spreads by blood to bone and lung.
- Both take up iodine and make thyroglobulin.
- 8.
Tell me about medullary carcinoma of the thyroid.
Show answer
- From parafollicular C cells; secretes calcitonin; amyloid stroma.
- A quarter familial with RET mutations in MEN 2.
- Screen relatives; exclude phaeochromocytoma before surgery.
- Does not take up radioiodine.
- 9.
Why is skin cancer so common in Australia and New Zealand?
Show answer
- High ultraviolet levels and outdoor lifestyle.
- Population with fair skin of northern European ancestry.
- UVB forms pyrimidine dimers; TP53 and other mutations follow.
- Immunosuppressed transplant recipients have a much higher risk of squamous cell carcinoma.
Practise this week
Week 11 in the other subjects
- Anatomy: Leg, ankle and foot
- Physiology: Ventilation, dead space and V/Q matching
Not affiliated with the Royal Australasian College of Surgeons. Notes are a revision aid, not a substitute for the curriculum or for clinical guidelines.